{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:19:01Z","timestamp":1790284741777,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.03.099","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T14:16:24Z","timestamp":1492092984000},"page":"5487-5494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The in vitro MIMIC\u00ae platform reflects age-associated changes in immunological responses after influenza vaccination"],"prefix":"10.1016","volume":"35","author":[{"given":"Allison","family":"Dauner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Salvatico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenekua","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipra","family":"Dhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Farzana","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Donald R.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.099_b0005","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2105\/AJPH.2005.074583","article-title":"Assembling a global vaccine development pipeline for infectious diseases in the developing world","volume":"96","author":"Serdobova","year":"2006","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2017.03.099_b0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri3192-c2","article-title":"The storm has cleared: lessons from the CD28 superagonist TGN1412 trial","volume":"12","author":"Hunig","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.03.099_b0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nm.f.1759","article-title":"Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans","volume":"14","author":"Watkins","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.03.099_b0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.addr.2013.12.011","article-title":"Human immunity in vitro - solving immunogenicity and more","volume":"69\u201370","author":"Giese","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2017.03.099_b0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/dst.2012.0006","article-title":"In vitro biomimetic model of the human immune system for predictive vaccine assessments","volume":"1","author":"Drake","year":"2012","journal-title":"Disruptive Sci Technol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.03.099_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/026119290903701S05","article-title":"An immunologic model for rapid vaccine assessment \u2013 a clinical trial in a test tube","volume":"37","author":"Higbee","year":"2009","journal-title":"Altern Lab Anim: ATLA"},{"key":"10.1016\/j.vaccine.2017.03.099_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/1547691X.2011.613419","article-title":"A predictive biomimetic model of cytokine release induced by TGN1412 and other therapeutic monoclonal antibodies","volume":"9","author":"Dhir","year":"2012","journal-title":"J Immunotoxicol"},{"key":"10.1016\/j.vaccine.2017.03.099_b0040","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.4049\/jimmunol.172.6.3437","article-title":"Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly","volume":"172","author":"Deng","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.099_b0045","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/344271","article-title":"The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis","volume":"35","author":"Fisman","year":"2002","journal-title":"Clin Infect Dis: Official Pub Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2017.03.099_b0050","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.099_b0055","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.03.099_b0060","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.vaccine.2009.09.138","article-title":"Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002","volume":"28","author":"Voordouw","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.099_b0065","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.immuni.2015.11.012","article-title":"Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures","volume":"43","author":"Nakaya","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2017.03.099_b0070","unstructured":"Flu Vaccination Coverage: United States, 2014\u20132015 Influenza Season. CDC; 2016."},{"key":"10.1016\/j.vaccine.2017.03.099_b0075","unstructured":"Estimates of Deaths Associated with Seasonal Influenza - United States, 1976\u20132007. Morbidity and Mortality Weekly Report: CDC; 2010."},{"key":"10.1016\/j.vaccine.2017.03.099_b0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/1471-2334-14-425","article-title":"Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older","volume":"14","author":"Couch","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.099_b0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jim.2008.02.021","article-title":"A novel approach for the generation of human dendritic cells from blood monocytes in the absence of exogenous factors","volume":"335","author":"Schanen","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2017.03.099_b0090","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.vaccine.2011.02.019","article-title":"Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus","volume":"29","author":"Schanen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.099_b0095","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/JVI.02434-12","article-title":"Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine","volume":"87","author":"Rockman","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.03.099_b0100","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1172\/JCI57834","article-title":"Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies","volume":"121","author":"Sasaki","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2017.03.099_b0105","doi-asserted-by":"crossref","first-page":"171ra19","DOI":"10.1126\/scitranslmed.3004794","article-title":"Lineage structure of the human antibody repertoire in response to influenza vaccination","volume":"5","author":"Jiang","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2017.03.099_b0110","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.1302503","article-title":"Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults","volume":"193","author":"Herati","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.099_b0115","doi-asserted-by":"crossref","first-page":"246ps8","DOI":"10.1126\/scitranslmed.3008409","article-title":"Seeking help: B cells adapting to flu variability","volume":"6","author":"van der Most","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2017.03.099_b0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.03.099_b0125","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.03.099_b0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.it.2009.05.002","article-title":"Vaccination in the elderly: an immunological perspective","volume":"30","author":"Chen","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2017.03.099_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.099_b0140","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1016\/j.vaccine.2006.06.037","article-title":"Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers","volume":"24","author":"Kaml","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.099_b0145","unstructured":"FDA's Critical Path Initiative."},{"key":"10.1016\/j.vaccine.2017.03.099_b0150","doi-asserted-by":"crossref","first-page":"e0150812","DOI":"10.1371\/journal.pone.0150812","article-title":"Highly predictive model for a protective immune response to the A(H1N1)pdm2009 influenza strain after seasonal vaccination","volume":"11","author":"Jurchott","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.099_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/erv.09.148","article-title":"Animal models for the preclinical evaluation of candidate influenza vaccines","volume":"9","author":"Bodewes","year":"2010","journal-title":"Exp Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.099_b0160","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.1256427","article-title":"Antibody landscapes after influenza virus infection or vaccination","volume":"346","author":"Fonville","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.03.099_b0165","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0264-410X(94)90241-0","article-title":"Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial","volume":"12","author":"Govaert","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.099_b0170","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0264-410X(97)00019-4","article-title":"Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly","volume":"15","author":"de Bruijn","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.099_b0175","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiu647","article-title":"Influenza vaccine effectiveness in the United States during 2012\u20132013: variable protection by age and virus type","volume":"211","author":"McLean","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.099_b0180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.vaccine.2015.11.058","article-title":"The confounded effects of age and exposure history in response to influenza vaccination","volume":"34","author":"Mosterin Hopping","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.099_b0185","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1586\/14760584.2015.1040395","article-title":"Is the gut microbiome key to modulating vaccine efficacy?","volume":"14","author":"Nakaya","year":"2015","journal-title":"Exp Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T01:43:53Z","timestamp":1569030233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17304516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":37,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17304516"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.099","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The in vitro MIMIC\u00ae platform reflects age-associated changes in immunological responses after influenza vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}